Arcturus Therapeutics Holdings (ARCT) EPS (Basic) Growth (5y) (2023 - 2026)

Arcturus Therapeutics Holdings (ARCT) EPS (Basic) Growth (5y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Arcturus Therapeutics Holdings 164.57 Mn -46.81 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 4.60%
Dec 31, 2025 7.41%
Sep 30, 2025 12.66%
Jun 30, 2025 11.07%
Mar 31, 2025 7.09%
Dec 31, 2024 -4.05%
Sep 30, 2024 18.08%
Jun 30, 2024 4.31%
Mar 31, 2024 -8.58%
Dec 31, 2023 17.02%
Sep 30, 2023 -326.77%
Jun 30, 2023 -356.28%